Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

Lantheus increases shareholding in RAD with A$8m placement

Friday, January 10, 2025 1 min read
Key Takeaway: Lantheus has announced an A$8 million placement to increase its shareholding in RAD. This strategic move reflects Lantheus's confidence in RAD's future prospects. The additional capital is expected to support RAD's ongoing projects and initiatives.
Price reaction · baseline $4.15 (2025-01-10T16:38:00.000Z) · hit during market hours · 1 other RADX headline(s) in the window, move may be shared
day 0 close
+28.9%
day 1 · peak
+50.4%
day 3
+35.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus increases its shareholding in RAD, indicating confidence in the company.
  • The A$8 million placement may provide RAD with necessary capital for growth.

Full Press Release Details

• Announcements
• Price Sensitive
• January 10, 2025
Loading Viewer…

More Announcements & Updates

• Announcements
• October 29, 2024
• Announcements
• April 12, 2022
• Updates
• March 18, 2024
• Announcements
• November 23, 2021

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is the amount of Lantheus's investment in RAD?

Lantheus has invested A$8 million to increase its shareholding in RAD.

What does the investment by Lantheus signify?

The investment indicates Lantheus's confidence in RAD's future prospects.

How will RAD benefit from this placement?

The A$8 million placement is expected to provide RAD with necessary capital for growth.

Tags: RADX Viatris Investor Conferences Healthcare Lantheus investment clinical study capital raising
Last updated: Jan 10, 2025